A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.
Cre/loxP
bacterial artificial chromosome
embryonic stem cells
gene targeting
liver steatosis
recombineering
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Aug 2019
22 Aug 2019
Historique:
received:
06
08
2019
accepted:
16
08
2019
entrez:
25
8
2019
pubmed:
25
8
2019
medline:
25
8
2019
Statut:
epublish
Résumé
Genetically-engineered mouse models (GEMMs) lacking diseased-associated gene(s) globally or in a tissue-specific manner represent an attractive tool with which to assess the efficacy and toxicity of targeted pharmacological inhibitors.
Identifiants
pubmed: 31443474
pii: cancers11091226
doi: 10.3390/cancers11091226
pmc: PMC6770775
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Science Fund
ID : P29222
Organisme : Austrian Science Fund
ID : P 25599
Organisme : Austrian Science Fund FWF
ID : P 25599
Pays : Austria
Organisme : Austrian Science Fund
ID : P25925
Organisme : Austrian Science Fund
ID : P26908
Références
Mol Cell Biol. 2004 Sep;24(18):8037-47
pubmed: 15340066
Endocrinology. 2013 Jul;154(7):2434-45
pubmed: 23696567
Biomol Ther (Seoul). 2014 Jul;22(4):267-74
pubmed: 25143803
Genesis. 2002 Jan;32(1):19-26
pubmed: 11835670
PLoS Genet. 2014 Jan 30;10(1):e1004125
pubmed: 24497841
J Exp Med. 2009 Apr 13;206(4):819-31
pubmed: 19332876
Genesis. 2002 Feb;32(2):161-4
pubmed: 11857809
Nucleic Acids Res. 1992 Jul 25;20(14):3795-6
pubmed: 1641353
Endocrinology. 2008 Apr;149(4):1581-90
pubmed: 18096662
Hepatology. 2010 Apr;51(4):1319-26
pubmed: 20162728
Br J Haematol. 2002 Mar;116(4):758-64
pubmed: 11886378
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12929-34
pubmed: 14566054
J Immunol. 1998 Nov 1;161(9):4652-60
pubmed: 9794394
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10933-8
pubmed: 8855286
J Biol Chem. 2007 Jul 13;282(28):20059-63
pubmed: 17502367
Mol Biotechnol. 2006 Jan;32(1):43-53
pubmed: 16382181
Hepatology. 2007 Aug;46(2):504-13
pubmed: 17640041
Mol Cell Biol. 2000 Jan;20(2):648-55
pubmed: 10611243
Nat Methods. 2009 Jul;6(7):493-5
pubmed: 19525957
Int J Dev Neurosci. 2000 Oct;18(6):615-8
pubmed: 10884606
J Cell Sci. 2004 Mar 15;117(Pt 8):1281-3
pubmed: 15020666
Nat Biotechnol. 2003 Apr;21(4):443-7
pubmed: 12627172
Nucleic Acids Res. 1999 Mar 15;27(6):1555-7
pubmed: 10037821
Mol Cell Biol. 2001 Mar;21(5):1621-32
pubmed: 11238899
Immunity. 2002 Jul;17(1):63-72
pubmed: 12150892
J Autoimmun. 2013 Oct;46:25-34
pubmed: 23948302
J Biol Chem. 1999 Dec 31;274(53):38071-82
pubmed: 10608876
Annu Rev Med. 2015;66:311-28
pubmed: 25587654
Gastroenterology. 2010 Jun;138(7):2499-508
pubmed: 20193684
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1879-84
pubmed: 12571365
Methods Enzymol. 2013;533:133-55
pubmed: 24182921
Genesis. 2000 Feb;26(2):151-3
pubmed: 10686615
Cytogenet Genome Res. 2015;147(1):1-9
pubmed: 26583376
Oncogene. 2016 Feb 25;35(8):939-51
pubmed: 25982279
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801-4
pubmed: 9108058
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
Front Oncol. 2019 Feb 21;9:48
pubmed: 30847297
Haematologica. 2017 Sep;102(9):1519-1529
pubmed: 28596283
Nat Biotechnol. 2003 Apr;21(4):447-51
pubmed: 12627171
Immunity. 2015 Jul 21;43(1):200-9
pubmed: 26163370
Physiol Genomics. 2009 Apr 10;37(2):140-6
pubmed: 19141541
Nucleic Acids Res. 2012 Oct;40(19):e150
pubmed: 22753106
Cold Spring Harb Symp Quant Biol. 1997;62:159-68
pubmed: 9598348